Home/Filings/4/0001415889-24-025334
4//SEC Filing

Howze Yalonda 4

Accession 0001415889-24-025334

CIK 0001733294other

Filed

Oct 16, 8:00 PM ET

Accepted

Oct 17, 4:05 PM ET

Size

8.6 KB

Accession

0001415889-24-025334

Insider Transaction Report

Form 4
Period: 2024-10-15
Howze Yalonda
CHIEF LEGAL OFFICER
Transactions
  • Exercise/Conversion

    Common Stock

    2024-10-15$2.42/sh+3,347$8,10015,169 total
  • Tax Payment

    Common Stock

    2024-10-1598314,186 total
  • Exercise/Conversion

    Restricted Stock Units

    2024-10-153,34733,468 total
    Common Stock (3,347 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit represents the right to receive one share of the company's common stock.
  • [F2]The grant of 53,550 restricted stock units was made on April 5, 2023. The shares underlying the restricted stock units vest over four years, with 25% of the shares vested on April 15, 2024 and the remaining shares vesting in equal quarterly installments thereafter.

Issuer

Generation Bio Co.

CIK 0001733294

Entity typeother

Related Parties

1
  • filerCIK 0001828153

Filing Metadata

Form type
4
Filed
Oct 16, 8:00 PM ET
Accepted
Oct 17, 4:05 PM ET
Size
8.6 KB